ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape

  • André E. Nel*
    André E. Nel
    Division of NanoMedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, United States
    California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States
    *Phone: 310.825.6620. E-mail: [email protected]
    More by André E. Nel
  •  and 
  • Jeff F. Miller
    Jeff F. Miller
    California NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United States
    Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, California 90095, United States
    More by Jeff F. Miller
Cite this: ACS Nano 2021, 15, 4, 5793–5818
Publication Date (Web):April 1, 2021
https://doi.org/10.1021/acsnano.1c01845
Copyright © 2021 American Chemical Society

    Article Views

    8390

    Altmetric

    -

    Citations

    32
    LEARN ABOUT THESE METRICS
    Other access options

    Abstract

    Abstract Image

    At the time of preparing this Perspective, large-scale vaccination for COVID-19 is in progress, aiming to bring the pandemic under control through vaccine-induced herd immunity. Not only does this vaccination effort represent an unprecedented scientific and technological breakthrough, moving us from the rapid analysis of viral genomes to design, manufacture, clinical trial testing, and use authorization within the time frame of less than a year, but it also highlights rapid progress in the implementation of nanotechnology to assist vaccine development. These advances enable us to deliver nucleic acid and conformation-stabilized subunit vaccines to regional lymph nodes, with the ability to trigger effective humoral and cellular immunity that prevents viral infection or controls disease severity. In addition to a brief description of the design features of unique cationic lipid and virus-mimicking nanoparticles for accomplishing spike protein delivery and presentation by the cognate immune system, we also discuss the importance of adjuvancy and design features to promote cooperative B- and T-cell interactions in lymph node germinal centers, including the use of epitope-based vaccines. Although current vaccine efforts have demonstrated short-term efficacy and vaccine safety, key issues are now vaccine durability and adaptability against viral variants. We present a forward-looking perspective of how vaccine design can be adapted to improve durability of the immune response and vaccine adaptation to overcome immune escape by viral variants. Finally, we consider the impact of nano-enabled approaches in the development of COVID-19 vaccines for improved vaccine design against other infectious agents, including pathogens that may lead to future pandemics.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 32 publications.

    1. Warren C. W. Chan, Natalie Artzi, Chunying Chen, Xiaodong Chen, Dean Ho, Tony Hu, Kazunori Kataoka, Luis M. Liz-Marzán, Rahmi Oklu, Wolfgang J. Parak. Noble Nanomedicine: Celebrating Groundbreaking mRNA Vaccine Innovations. ACS Nano 2023, 17 (20) , 19476-19477. https://doi.org/10.1021/acsnano.3c09781
    2. Ceri J. Richards, Thomas C. Q. Burgers, Rifka Vlijm, Wouter H. Roos, Christoffer Åberg. Rapid Internalization of Nanoparticles by Human Cells at the Single Particle Level. ACS Nano 2023, 17 (17) , 16517-16529. https://doi.org/10.1021/acsnano.3c01124
    3. Maurice Retout, Benedetta Cornelio, Gilles Bruylants, Ivan Jabin. Bifunctional Calix[4]arene-Coated Gold Nanoparticles for Orthogonal Conjugation. Langmuir 2022, 38 (30) , 9301-9309. https://doi.org/10.1021/acs.langmuir.2c01122
    4. Nuri Burak Kiremitler, Munteha Zeynep Kemerli, Nilgun Kayaci, Sultan Karagoz, Sami Pekdemir, Gokhan Sarp, Senem Sanduvac, Mustafa Serdar Onses, Erkan Yilmaz. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Applied Nano Materials 2022, 5 (5) , 6029-6054. https://doi.org/10.1021/acsanm.2c00181
    5. Morgan Chandler, Brittany Johnson, Emil Khisamutdinov, Marina A. Dobrovolskaia, Joanna Sztuba-Solinska, Aliasger K. Salem, Koen Breyne, Roger Chammas, Nils G. Walter, Lydia M. Contreras, Peixuan Guo, Kirill A. Afonin. The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field. ACS Nano 2021, 15 (11) , 16957-16973. https://doi.org/10.1021/acsnano.0c10240
    6. Wolfgang J. Parak, (Associate Editor)Tanja Weil, (Editorial Advisory Board and Associate Editor of the Journal of the American Chemical Society)Paul S. Weiss (Editor-in-Chief). A Virtual Issue on Nanomedicine. ACS Nano 2021, 15 (10) , 15397-15401. https://doi.org/10.1021/acsnano.1c09106
    7. Paul S. Weiss (Editor-in-Chief). Touting the Growing Contributions of Nanoscience and Nanotechnology. ACS Nano 2021, 15 (7) , 10737-10738. https://doi.org/10.1021/acsnano.1c05996
    8. Istuti Saraswat, Sarmistha Saha, Anuja Mishra. A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Toxicology and Environmental Health Sciences 2023, 15 (4) , 315-324. https://doi.org/10.1007/s13530-023-00182-9
    9. Xirong Wang, Shulin Shao, Huan Ye, Sen Li, Bing Gu, Bo Tang. Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies. Scientific Reports 2023, 13 (1) https://doi.org/10.1038/s41598-023-49244-5
    10. Yanhao Zhang, Ji Wang, Hanlei Xing, Chao Liu, Wenhui Zha, Shuo Dong, Yuhao Jiang, Xinsong Li. Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection. Journal of Materials Chemistry B 2023, 11 (31) , 7454-7465. https://doi.org/10.1039/D3TB00303E
    11. Tianyu Zhao, Penghui Liang, Jiaqi Ren, Jinyue Zhu, Xianning Yang, Hongyu Bian, Jingwen Li, Xiaofeng Cui, Chunhui Fu, Jinyan Xing, Congying Wen, Jingbin Zeng. Gold-silver alloy hollow nanoshells-based lateral flow immunoassay for colorimetric, photothermal, and SERS tri-mode detection of SARS-CoV-2 neutralizing antibody. Analytica Chimica Acta 2023, 1255 , 341102. https://doi.org/10.1016/j.aca.2023.341102
    12. Priya Shrivastava, Suresh P. Vyas. COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions. 2023, 269-294. https://doi.org/10.1007/978-3-031-20537-8_12
    13. Mohamed E. Elnosary, Hesham A. Aboelmagd, Manal A. Habaka, Salem R. Salem, Mehrez E. El-Naggar. Synthesis of bee venom loaded chitosan nanoparticles for anti-MERS-COV and multi-drug resistance bacteria. International Journal of Biological Macromolecules 2023, 224 , 871-880. https://doi.org/10.1016/j.ijbiomac.2022.10.173
    14. Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble, Sathiah Thennarasu. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity. Molecular Biomedicine 2022, 3 (1) https://doi.org/10.1186/s43556-022-00078-z
    15. Lifeng Wang, Zhiwei Li. Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination. Biosensors 2022, 12 (12) , 1129. https://doi.org/10.3390/bios12121129
    16. Kevork Oliver Messerian, Anton Zverev, Jack F. Kramarczyk, Andrew L. Zydney. Pressure‐dependent fouling behavior during sterile filtration of mRNA‐containing lipid nanoparticles. Biotechnology and Bioengineering 2022, 119 (11) , 3221-3229. https://doi.org/10.1002/bit.28200
    17. Rahul Bhattacharjee, Ankit Kumar Dubey, Archisha Ganguly, Basudha Bhattacharya, Yogendra Kumar Mishra, Ebrahim Mostafavi, Ajeet Kaushik. State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic. OpenNano 2022, 8 , 100078. https://doi.org/10.1016/j.onano.2022.100078
    18. Ziqi Wang, Kai Cui, Ulrich Costabel, Xiaoju Zhang. Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic. Exploration 2022, 2 (5) https://doi.org/10.1002/EXP.20210082
    19. Haoyang Tong, Chaoyu Cao, Minli You, Shuang Han, Zhe Liu, Ying Xiao, Wanghong He, Chang Liu, Ping Peng, Zhenrui Xue, Yan Gong, Chunyan Yao, Feng Xu. Artificial intelligence-assisted colorimetric lateral flow immunoassay for sensitive and quantitative detection of COVID-19 neutralizing antibody. Biosensors and Bioelectronics 2022, 213 , 114449. https://doi.org/10.1016/j.bios.2022.114449
    20. Jongwon Park. Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing. Sensors 2022, 22 (19) , 7398. https://doi.org/10.3390/s22197398
    21. João Lima Tavares, Iago Dillion Lima Cavalcanti, Nereide Stela Santos Magalhães, Mariane Cajubá de Britto Lira Nogueira. Nanotechnology and COVID-19: quo vadis?. Journal of Nanoparticle Research 2022, 24 (3) https://doi.org/10.1007/s11051-022-05452-0
    22. Shivani Tiwari, Subhavna Juneja, Anujit Ghosal, Nandika Bandara, Raju Khan, Scott L. Wallen, Seeram Ramakrishna, Ajeet Kaushik. Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern. Current Opinion in Biomedical Engineering 2022, 21 , 100363. https://doi.org/10.1016/j.cobme.2021.100363
    23. Hylemariam Mihiretie Mengist, John Arnaud Kombe Kombe, Tengchuan Jin. Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant. Infection and Drug Resistance 2022, Volume 15 , 4013-4027. https://doi.org/10.2147/IDR.S366437
    24. Ali Dogan Dursun, Ersin Saricam, Gulcin Turkmen Sariyildiz, Murat Doğan Iscanli, Ömer Faruk Cantekin. The Evaluation of Oxidative Stress in the Young Adults with COVID-19 mRNA Vaccines Induced Acute Pericarditis- Myopericarditis. International Journal of General Medicine 2022, Volume 15 , 161-167. https://doi.org/10.2147/IJGM.S347977
    25. Madhura Kamat, Vishakha Kurlawala, Geetanjali Ghosh, Radhika Vaishnav. Immune dynamics of SARS-CoV-2 virus evolution. International Journal of Molecular and Immuno Oncology 2022, 7 , 3-15. https://doi.org/10.25259/IJMIO_26_2021
    26. Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, Negin Noorbakhsh, Negin Borzooee Moghadam, Matin Mamoudifard. A comprehensive review on efficient approaches for combating coronaviruses. Biomedicine & Pharmacotherapy 2021, 144 , 112353. https://doi.org/10.1016/j.biopha.2021.112353
    27. Hui-Tsu Lin, Cheng-Cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-An Chen, Jenn-Jong Young, Szu-Cheng Kuo. Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice. International Journal of Biological Macromolecules 2021, 193 , 1885-1897. https://doi.org/10.1016/j.ijbiomac.2021.11.020
    28. Maryam Hojjat Jodaylami, Abdelhadi Djaïleb, Pierre Ricard, Étienne Lavallée, Stella Cellier-Goetghebeur, Megan-Faye Parker, Julien Coutu, Matthew Stuible, Christian Gervais, Yves Durocher, Florence Desautels, Marie-Pierre Cayer, Marie Joëlle de Grandmont, Samuel Rochette, Danny Brouard, Sylvie Trottier, Denis Boudreau, Joelle N. Pelletier, Jean-Francois Masson. Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins. Scientific Reports 2021, 11 (1) https://doi.org/10.1038/s41598-021-00844-z
    29. Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque, Nihad Adnan. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines 2021, 9 (12) , 1387. https://doi.org/10.3390/vaccines9121387
    30. Lei Qiao, Minmin Chen, Suyan Li, Jinxia Hu, Chaoju Gong, Zhuoqi Zhang, Xichuan Cao. A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice. Biomaterials Science 2021, 9 (21) , 7287-7296. https://doi.org/10.1039/D1BM01060C
    31. Catherine H. Schein, Corri B. Levine, Susan L.F. McLellan, Surendra S. Negi, Werner Braun, Stephen C. Dreskin, Elizabeth S. Anaya, Jurgen Schmidt. Synthetic proteins for COVID-19 diagnostics. Peptides 2021, 143 , 170583. https://doi.org/10.1016/j.peptides.2021.170583
    32. Abdel-Majed Safer, Stefano Leporatti. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment. International Journal of Nanomedicine 2021, Volume 16 , 8141-8158. https://doi.org/10.2147/IJN.S332385

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect